Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Diffuse Cutaneous Systemic Sclerosis”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Testing effectiveness (Phase 2)Looking for participantsNCT05149768
What this trial is testing

Open Label Extension Study of Brentuximab Vedotin in Early dcSSc

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 11
Testing effectiveness (Phase 2)Study completedNCT02370784
What this trial is testing

Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma

Who this might be right for
Scleroderma
Robyn T. Domsic, MD, MPH 24
Testing effectiveness (Phase 2)Study completedNCT01670565
What this trial is testing

Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Hospital for Special Surgery, New York 20
Not applicableWithdrawnNCT02531009
What this trial is testing

Systemic Sclerosis Clinical and Biomarker Study

Who this might be right for
HealthySystemic Sclerosis
Biogen
Testing effectiveness (Phase 2)Study completedNCT03274076
What this trial is testing

Evaluation of Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis (dcSSc)

Who this might be right for
Systemic SclerosisScleroderma
University of Michigan 15
Not applicableStudy completedNCT02339441
What this trial is testing

Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Early Diffuse Cutaneous Systemic Sclerosis
University of Manchester 320
Large-scale testing (Phase 3)UnknownNCT00428883
What this trial is testing

High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic Sclerosis

Who this might be right for
Scleroderma, Diffuse
Università Politecnica delle Marche 45
Testing effectiveness (Phase 2)Study completedNCT03708718
What this trial is testing

Prednisolone in Early Diffuse Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Prof. Ariane herrick 35
Testing effectiveness (Phase 2)Study completedNCT03198689
What this trial is testing

Brentuximab Vedotin in Early Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 11
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04986605
What this trial is testing

Extracorporeal Photopheresis in Early Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 15
Testing effectiveness (Phase 2)Looking for participantsNCT06375005
What this trial is testing

Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Second Affiliated Hospital, School of Medicine, Zhejiang University 38
Testing effectiveness (Phase 2)Study completedNCT00043706
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis

Who this might be right for
Systemic SclerosisScleroderma
Genzyme, a Sanofi Company
Post-approval studies (Phase 4)Looking for participantsNCT04464434
What this trial is testing

Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Systemic SclerosisSystemic Scleroses, DiffuseScleroderma+5 more
UMC Utrecht 50